Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Evaluate the Safety”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06561321
What this trial is testing

Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma

Who this might be right for
Palmoplantar Keratoderma
Indiana University 6
Early research (Phase 1)Study completedNCT06337604
What this trial is testing

The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets

Who this might be right for
Helicobacter Pylori Infection
TenNor Therapeutics Inc. 20
Testing effectiveness (Phase 2)Study completedNCT03807804
What this trial is testing

Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome

Who this might be right for
Respiratory Distress Syndrome, Adult
Healios K.K. 35
Testing effectiveness (Phase 2)Temporarily pausedNCT06211933
What this trial is testing

Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS)

Who this might be right for
Non-Resectable Pancreas Carcinoma
Centre Leon Berard 26
Not applicableStudy completedNCT05385952
What this trial is testing

GATT-Patch Versus TachoSil in Liver Surgery

Who this might be right for
Intraoperative BleedingHemorrhage, SurgicalLiver Diseases
GATT Technologies BV 132
Testing effectiveness (Phase 2)Study completedNCT04088149
What this trial is testing

An Open-labeled Phase II Study to Evaluate the Efficacy and Safety of GXNPC-1 in Patients with Chronic Stroke

Who this might be right for
Chronic Stroke
Gwo Xi Stem Cell Applied Technology Co., Ltd. 12
Post-approval studies (Phase 4)Study completedNCT00119158
What this trial is testing

Combination Therapy for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Children's Hospital of Philadelphia 90
Large-scale testing (Phase 3)Looking for participantsNCT07196748
What this trial is testing

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 882
Not applicableEnded earlyNCT00981578
What this trial is testing

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

Who this might be right for
Bone Metastases
InSightec 37
Not applicableStudy completedNCT05463978
What this trial is testing

Sculptra Chart Review

Who this might be right for
Non-facial Skin Aesthetic Conditions
Galderma R&D 498
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06463678
What this trial is testing

Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis

Who this might be right for
Fungal Keratitis
IVIEW Therapeutics Inc. 60
Large-scale testing (Phase 3)Study completedNCT06088043
What this trial is testing

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

Who this might be right for
Plaque Psoriasis
Takeda 693
Large-scale testing (Phase 3)UnknownNCT04667143
What this trial is testing

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy

Who this might be right for
Diabetes Mellitus, Type II
Jiangsu HengRui Medicine Co., Ltd. 760
Testing effectiveness (Phase 2)Study completedNCT07120308
What this trial is testing

To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis

Who this might be right for
Corneal Epithelial Defect
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. 28
Early research (Phase 1)Study completedNCT01057108
What this trial is testing

Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia

Who this might be right for
HyperphosphatemiaChronic Kidney Disease
Denver Nephrologists, P.C. 121
Testing effectiveness (Phase 2)Study completedNCT00002235
What this trial is testing

A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 6
Large-scale testing (Phase 3)Study completedNCT01929044
What this trial is testing

Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal Pain

Who this might be right for
Intestinal Diseases
Boehringer Ingelheim 299
Early research (Phase 1)Study completedNCT00000999
What this trial is testing

The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 500
Early research (Phase 1)Study completedNCT02528799
What this trial is testing

Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease

Who this might be right for
Celiac Disease
ImmusanT, Inc. 38
Large-scale testing (Phase 3)WithdrawnNCT04483687
What this trial is testing

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy

Who this might be right for
Ankylosing Spondylitis
Gilead Sciences
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation